Liraglutide improves antioxidant defense in hearts of spontaneously hypertensive female rats independently of changes in blood pressure in a pre-clinical model of menopause
Open Access
- 1 January 2025
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 58, e14209
Abstract
Liraglutide (LIRA) is an agonist of the GLP-1 receptor used in the treatment of type 2 diabetes with a cardioprotective effect, although little is known about the effects of LIRA in post-menopause. We aimed to evaluate the effects of LIRA in the cardiovascular system of ovariectomized spontaneously hypertensive rats (SHR). SHR rats were separated into two groups: ovariectomized (saline) and ovariectomized + liraglutide (0.6 and 1.2 mg/kg for 4+4 weeks, respectively). Systolic blood pressure (SBP) was indirectly evaluated at the beginning and end of treatment. Diastolic, systolic, and mean blood pressure were evaluated in the carotid artery of anesthetized animals, while left ventricle systolic blood pressure (LVSBP) and left ventricle derivatives (-dP/dt; +dP/dt) were evaluated in the left ventricle. An oral glucose tolerance test (GTT) was conducted. Antioxidant enzymes and calcium-handling proteins were analyzed in heart tissue by western blot. Treatment with LIRA increased the expression of antioxidant enzymes (superoxide dismutase (SOD2) and catalase). No changes were observed in the GTT, cardiac hemodynamics, blood pressure, and calcium-handling protein expression. A decrease in visceral fat depot was observed without changes in final body weight. LIRA induced an antioxidant subclinical effect in ovariectomized SHR female rats without changing glucose metabolism and cardiac blood pressure.Keywords
Funding Information
- Espírito Santo Research Support Foundation (Notice 591/2018)
- Espírito Santo Research Support Foundation (Notice FAPES 06/2021 (TO 361/2022) and Notice 15/2022 (Profix))
- Espírito Santo Research Support Foundation (Notice FAPES/CNPq 23/2018)
- Espírito Santo Research Support Foundation (001)
- Coordination for the Improvement of Higher Education Personnel (Notice 591/2018)
- Coordination for the Improvement of Higher Education Personnel (Notice FAPES 06/2021 (TO 361/2022) and Notice 15/2022 (Profix))
- Coordination for the Improvement of Higher Education Personnel (Notice FAPES/CNPq 23/2018)
- Coordination for the Improvement of Higher Education Personnel (001)
This publication has 37 references indexed in Scilit:
- Liraglutide improves lipid and carbohydrate metabolism of ovariectomized ratsMolecular and Cellular Endocrinology, 2021
- GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunctionChemico-Biological Interactions, 2020
- A role of PLC/PKC-dependent pathway in GLP-1-stimulated insulin secretionJournal of Molecular Medicine, 2017
- Chronic fructose intake accelerates non-alcoholic fatty liver disease in the presence of essential hypertensionJournal of Diabetes and its Complications, 2016
- One-year metabolic outcomes in patients with type 2 diabetes treated with exenatide in routine practiceDiabetes & Metabolism, 2010
- The incretin system and cardiometabolic diseaseCanadian Journal of Cardiology, 2010
- Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trialDiabetologia, 2009
- The women's health initiative postmenopausal hormone trials: overview and baseline characteristics of participantsAnnals of Epidemiology, 2003
- Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signalingTrends in Endocrinology & Metabolism, 2002
- Protective effects of estrogen on the cardiovascular systemThe American Journal of Cardiology, 2002